Ashish V. Shah

home / authors / ashish-v-shah

CEO of Dina

Articles

As Home-Based Supplemental Benefits Explode, Health Plans Embrace Digital Tools to Improve Access to Services

As Home-Based Supplemental Benefits Explode, Health Plans Embrace Digital Tools to Improve Access to Services

Ashish V. Shah
December 5th 2022

Payers face the logistical challenge of coordinating a network of new, non-medical services to ensure members are referred to the right provider at the right time.

Read More

Navigating the Shift to Home-Based Care: 4 Strategies for Success | Ashish V. Shah

Navigating the Shift to Home-Based Care: 4 Strategies for Success | Ashish V. Shah

Ashish V. Shah
July 8th 2022

One trend to keep an eye on is the establishment of “care traffic control” centers to remotely monitor patients and use home-based insights to identify risks and inform care plans.

Read More

Latest Updated Articles

man looking at screen with gene images | ©muhammad stock.adobe.com
Published: December 10th 2024 | Updated: December 26th 2024
Next-Generation Testing Cheaper and More Effective for Guiding Lung Cancer Treatment
Pills balancing on top of each other | Image credit: James Thew - stock.adobe.com
Published: July 20th 2020 | Updated: December 26th 2024
For Better HCQ Retinopathy Guidelines, Include Prescribing Physicians
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
Published: October 3rd 2024 | Updated: December 26th 2024
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
Published: October 7th 2024 | Updated: December 26th 2024
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
Published: November 7th 2024 | Updated: December 26th 2024
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
Published: July 11th 2024 | Updated: December 26th 2024
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
© 2024 MJH Life Sciences

All rights reserved.